Metformin in the Diastolic Dysfunction of Metabolic Syndrome: MET-DIME Trial

Trial Profile

Metformin in the Diastolic Dysfunction of Metabolic Syndrome: MET-DIME Trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Metformin (Primary)
  • Indications Diastolic heart failure; Left ventricular dysfunction; Metabolic syndrome
  • Focus Therapeutic Use
  • Acronyms MET-DIME
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Dec 2015 Planned End Date changed from 1 Oct 2016 to 1 Nov 2017as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top